| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Almyra Oveta Fuller
|
Bagcchi, Sanjeet
|
|
|
23 |
2 |
p. 162
|
artikel
|
| 2 |
A novel tool to eradicate an ancient scourge: the novel oral polio vaccine type 2 story
|
Bandyopadhyay, Ananda S
|
|
|
23 |
2 |
p. e67-e71
|
artikel
|
| 3 |
Antibiotic review kit for hospitals (ARK-Hospital): a stepped-wedge cluster-randomised controlled trial
|
Llewelyn, Martin J
|
|
|
23 |
2 |
p. 207-221
|
artikel
|
| 4 |
Antimicrobial resistance through the looking-GLASS
|
The Lancet Infectious Diseases,
|
|
|
23 |
2 |
p. 131
|
artikel
|
| 5 |
A trial for Ebola Sudan virus in Uganda
|
Nakkazi, Esther
|
|
|
23 |
2 |
p. 158
|
artikel
|
| 6 |
Can group A streptococcus infections be influenced by viruses in the respiratory tract?
|
Turner, Claire E
|
|
|
23 |
2 |
p. 142-144
|
artikel
|
| 7 |
Correction to Lancet Infect Dis 2022; 22: 1052–61
|
|
|
|
23 |
2 |
p. e47
|
artikel
|
| 8 |
Correction to Lancet Infect Dis 2022; published online Nov 18. https://doi.org/10.1016/S1473-3099(22)00733-2
|
|
|
|
23 |
2 |
p. e47
|
artikel
|
| 9 |
Correction to Lancet Infect Dis 2022; published online Nov 29. https://doi.org/10.1016/S1473-3099(22)00660-0
|
|
|
|
23 |
2 |
p. e47
|
artikel
|
| 10 |
COVID-19 in the MENA region
|
Abbara, Aula
|
|
|
23 |
2 |
p. 166
|
artikel
|
| 11 |
Dimie Ogoina—Nigeria's expert in mpox
|
Kirby, Tony
|
|
|
23 |
2 |
p. 164
|
artikel
|
| 12 |
Déjà vu all over again? Monkeypox and the urgent need for randomised controlled trials
|
Lindholm, David A
|
|
|
23 |
2 |
p. e56-e58
|
artikel
|
| 13 |
Effectiveness of primary series and booster vaccination against SARS-CoV-2 infection and hospitalisation among adolescents aged 12–17 years in Singapore: a national cohort study
|
Chiew, Calvin J
|
|
|
23 |
2 |
p. 177-182
|
artikel
|
| 14 |
Effect of long-lasting insecticidal nets with and without piperonyl butoxide on malaria indicators in Uganda (LLINEUP): final results of a cluster-randomised trial embedded in a national distribution campaign
|
Maiteki-Sebuguzi, Catherine
|
|
|
23 |
2 |
p. 247-258
|
artikel
|
| 15 |
Ending tuberculosis in a post-COVID-19 world: a person-centred, equity-oriented approach
|
Ryckman, Theresa
|
|
|
23 |
2 |
p. e59-e66
|
artikel
|
| 16 |
Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study
|
Angelo, Kristina M
|
|
|
23 |
2 |
p. 196-206
|
artikel
|
| 17 |
Fighting insecticide resistance in malaria control
|
Zinszer, Kate
|
|
|
23 |
2 |
p. 138-139
|
artikel
|
| 18 |
HPV vaccination and cervical cancer screening in Afghanistan threatened
|
Awan, Usman Ayub
|
|
|
23 |
2 |
p. 141-142
|
artikel
|
| 19 |
Hypertrophic verrucous lesions after monkeypox virus infection
|
Scotti, Biagio
|
|
|
23 |
2 |
p. 259
|
artikel
|
| 20 |
Impact of influenza vaccination on hospitalised patients in South America
|
Gamiño-Arroyo, Ana Estela
|
|
|
23 |
2 |
p. 136-138
|
artikel
|
| 21 |
Inadequate diagnostic capacity for monkeypox—sleeping through the alarm again
|
Boodman, Carl
|
|
|
23 |
2 |
p. 140-141
|
artikel
|
| 22 |
Infections caused by Clostridium perfringens and Paeniclostridium sordellii after unsafe abortion
|
Aronoff, David M
|
|
|
23 |
2 |
p. e48-e55
|
artikel
|
| 23 |
Infectious disease surveillance update
|
Zwizwai, Ruth
|
|
|
23 |
2 |
p. 160
|
artikel
|
| 24 |
Learning and confirming in publicly funded antiviral trials
|
Standing, Joseph F
|
|
|
23 |
2 |
p. 132-133
|
artikel
|
| 25 |
Minoarisoa Rajerison—fighting plague in Madagascar
|
Kazi, Farooq
|
|
|
23 |
2 |
p. 163
|
artikel
|
| 26 |
Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial
|
Khoo, Saye H
|
|
|
23 |
2 |
p. 183-195
|
artikel
|
| 27 |
7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection
|
Marking, Ulrika
|
|
|
23 |
2 |
p. 150-152
|
artikel
|
| 28 |
mRNA vaccine technology for a multivalent flu vaccine
|
Kirby, Tony
|
|
|
23 |
2 |
p. 157
|
artikel
|
| 29 |
National case series of group A streptococcus pleural empyema in children: clinical and microbiological features
|
Holdstock, Victoria
|
|
|
23 |
2 |
p. 154-156
|
artikel
|
| 30 |
Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage
|
Arora, Prerna
|
|
|
23 |
2 |
p. 147-148
|
artikel
|
| 31 |
New tools for antibiotic stewardship: a lesson for prescribers, researchers, or policy makers?
|
Tacconelli, Evelina
|
|
|
23 |
2 |
p. 135-136
|
artikel
|
| 32 |
Partial ileectomy for intestinal Komagataella phaffii and Fusobacterium mortiferum co-infection
|
Liu, Mengting
|
|
|
23 |
2 |
p. 260
|
artikel
|
| 33 |
Race, inequalities, and burden of COVID-19 in the USA
|
Bisbas, Georgia
|
|
|
23 |
2 |
p. 165
|
artikel
|
| 34 |
Relaxation of anti-COVID-19 measures reveals new challenges for infectious disease outbreak forecasting
|
Brady, Oliver J
|
|
|
23 |
2 |
p. 144-146
|
artikel
|
| 35 |
Research in brief
|
Devi, Sharmila
|
|
|
23 |
2 |
p. 161
|
artikel
|
| 36 |
Risk of reinfection, vaccine protection, and severity of infection with the BA.5 omicron subvariant: a nation-wide population-based study in Denmark
|
Hansen, Christian Holm
|
|
|
23 |
2 |
p. 167-176
|
artikel
|
| 37 |
Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase 1/2, randomised, double-blind, active comparator-controlled, multicentre, US-based trial
|
Platt, Heather
|
|
|
23 |
2 |
p. 233-246
|
artikel
|
| 38 |
Setting a realistic AWaRe target for primary care antibiotic use in LMICs
|
Ingelbeen, Brecht
|
|
|
23 |
2 |
p. 152-153
|
artikel
|
| 39 |
Severity of influenza illness by seasonal influenza vaccination status among hospitalised patients in four South American countries, 2013–19: a surveillance-based cohort study
|
Regan, Annette K
|
|
|
23 |
2 |
p. 222-232
|
artikel
|
| 40 |
Stability of hybrid versus vaccine immunity against BA.5 infection over 8 months
|
Malato, João
|
|
|
23 |
2 |
p. 148-150
|
artikel
|
| 41 |
The end of the mpox pandemic?
|
Burki, Talha
|
|
|
23 |
2 |
p. 159-160
|
artikel
|
| 42 |
The 2022 monkeypox outbreak: the need for clinical curiosity
|
Gordon, N Claire
|
|
|
23 |
2 |
p. 133-134
|
artikel
|
| 43 |
Tracking immune correlates of protection for emerging SARS-CoV-2 variants
|
Nilles, Eric J
|
|
|
23 |
2 |
p. 153-154
|
artikel
|
Tijdschrift beschrijving